RELAPSED ADULT AML
Clinical trials for RELAPSED ADULT AML explained in plain language.
Never miss a new study
Get alerted when new RELAPSED ADULT AML trials appear
Sign up with your email to follow new studies for RELAPSED ADULT AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cell therapy trial targets Tough-to-Treat blood cancer
Disease control Recruiting nowThis early-stage study is testing a new cell therapy for adults with acute myeloid leukemia (AML) that has returned or not responded to standard treatments. Doctors will collect a patient's own immune cells, modify them in a lab to better target the cancer, and then infuse them b…
Matched conditions: RELAPSED ADULT AML
Phase: PHASE1 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Experimental cell therapy tested for Tough-to-Treat blood cancer
Disease control Recruiting nowThis early-stage study is testing the safety of a personalized cell therapy called CD19 CAR-T for adults with acute myeloid leukemia (AML) that has returned or not responded to standard treatments. The therapy involves collecting a patient's own immune cells, genetically modifyin…
Matched conditions: RELAPSED ADULT AML
Phase: PHASE1 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New drug cocktail tested for leukemia that Won't quit
Disease control Recruiting nowThis study is testing whether adding a drug called chidamide to a standard two-drug treatment is safe and more effective for adults whose acute myeloid leukemia has come back or hasn't responded to prior therapy. The goal is to see if this three-drug combination can help more pat…
Matched conditions: RELAPSED ADULT AML
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC